Director Shareholding

AstraZeneca PLC 20 November 2003 DEALING BY DIRECTORS COMPANIES ACT 1985 SECTION 324/329 WE HEREBY INFORM YOU THAT, ON 19 NOVEMBER 2003, WE WERE NOTIFIED BY DR H L MOGREN, A DIRECTOR OF THE COMPANY, THAT, ON 19 NOVEMBER 2003, HE SOLD 6,535 OPTIONS OVER ASTRAZENECA PLC ORDINARY SHARES OF USD0.25 EACH. THESE OPTIONS WERE ORIGINALLY GRANTED TO DR MOGREN IN 1997 OVER SHARES IN ASTRA AB UNDER THE ASTRA SHAREHOLDER VALUE INCENTIVE PLAN. THE OPTIONS WERE SUBSEQUENTLY CONVERTED INTO OPTIONS OVER ORDINARY SHARES IN ASTRAZENECA PLC IN APRIL 1999. DETAILS OF THE UNDERLYING ASTRAZENECA SHARES OVER WHICH THE OPTIONS WERE HELD ARE AS FOLLOWS:- NUMBER OF ASTRAZENECA EFFECTIVE OPTION MARKET PRICE OF SHARES OVER PRICE PER ASTRAZENECA SHARES WHEN WHICH OPTIONS WERE HELD SHARE OPTIONS WERE SOLD 8,792 316.13SEK 358SEK FOLLOWING THIS TRANSACTION, DR MOGREN HOLDS OPTIONS OVER 261,184 ORDINARY SHARES OF ASTRAZENECA PLC. G H R MUSKER COMPANY SECRETARY 20 NOVEMBER 2003 This information is provided by RNS The company news service from the London Stock Exchange

Companies

AstraZeneca (AZN)
UK 100